Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib with platinum-based chemotherapy and maintenance in platinum-sensitive relapsed ovarian cancer
2007-001346-41Phase 2Terminated
- Sponsor
- Medical Research Council
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer, fallopian tube cancer (PFTC) and serous peritoneal carcinoma (PPSC) comparing Cediranib + chemotherapy -> cediranib maintenance, Cediranib + chemotherapy -> placebo maintenance and Placebo + chemotherapy -> placebo maintenance (3 arms). Primary endpoint: Safety. Started May 2007; status: terminated.
02
Drugs
cediranib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)serous peritoneal carcinoma (PPSC)
Beyond the preview
Go deeper on 2007-001346-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001346-41.